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Abstract. The main aim of this study was to evaluate the criterion validity and to estimate the 
cut-off score of the Depression scale (DS) and short Depression scale (DSs) for a new self-
report measure – Latvian Clinical Personality Inventory (LCPI). Usefulness of DS and DSs for 
identifying patients with major depression were analysed based on psychometric analysis of 
data acquired from psychiatric inpatient sample with depressive disorder (n = 37) in 
comparison to randomised stratified community subsample (n = 176) selected from the overall 
test development sample (N = 888). The present study was carried within the framework of the 
National Research Program (BIOMEDICINE) 2014 – 2017 (sub-project Nr.5.8.2.). It was 
shown that all 24 item of DS show good to excellent discrimination power. Cronbach’s alpha 
was 0.97 for DS and 0.95 for DSs in test development sample. For DS, the optimal cut-off score 
was 26 points (sensitivity 95%, specificity 91%, and positive predicted value of 69%). For DSs, 
the optimal cut-off was 12 points (sensitivity 92%, specificity 89%, and positive predicted value 
63%). DS and DSs of LCPI is proved to have good criterion validity in detecting depression 
and to be a reliable and valid instrument for assessment of depression symptoms in patients 
with depression and in general population. Subjects scoring at least 26 on DS or 12 points on 
DSs constitute a target group for further diagnostic assessment in order to determine 
appropriate treatment. 
Keywords: depression, criterion validity, reliability, screening, sensitivity, specificity. 
 
Introduction 
 
Depression, especially if left untreated, has considerable impact on 
individuals’ quality of life, on society and on the public health system (Mathers & 
Loncar, 2006) and is associated with serious consequences such as personal and 
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interpersonal suffering, impaired daily functioning, disturbance to interpersonal 
relationships, increased health care use, morbidity and an increased risk of suicide 
(e.g. Rihmer, 2007; Zlotnick at al., 2000). Depression is among the most 
commonly diagnosed mental disorders in adults. According to Latvian National 
Health Service, in 2015 depressive disorder was on the fifth place among all 
mental and behavioural disorders based on its relative frequency (Pulmanis, 
Japeniņa, Taube, 2016). Point prevalence of depression in the Latvian general 
population has been estimated to be 6.7% (Rancans, Vrublevska, Snikere, 
Koroleva, & Trapencieris, 2014), but 12-month prevalence of major depression 
has been estimated to be 7.9%, and for minor depression it was 7.7% (Vrublevska 
et al., 2017). Worldwide the prevalence of depressive disorders in primary care 
has been estimated to be between 10−20% (Mitchell, Vaze, & Rao, 2009), and in 
Latvia it was shown to be 10.2% in average with marked differences by gender 
(e.g. for male it was 6.0%, while for female it has been estimated to be 12.0%), 
and in lower extent with differences by age group (Rancans, Vrublevska, Kivite, 
et al.,  et al., 2016). 
Because depression is often undiagnosed and untreated, active screening of 
depression is warranted. Use of patient-administered screening tools has increased 
as a quick and reliable option in the first step of depression assessment or as a 
treatment monitor (Gilbody, Richards, Brealey, & Hewitt, 2007). In English 
language, many self-assessment instruments are available for practitioners for 
identifying patients with major depression or dysthymia in primary care settings, 
but in Latvian language only some of these instruments are available, and on the 
moment only one of them – Patient Health Questionnaire (PHQ-9) is standardised 
in Latvia (see Rancans, Vrublevska, Trapencieris et al., 2016).   
Screening of depression is essential not only in primary care settings, but 
also in occupational, educational, forensic and clinical settings. In these settings 
screening of general depression can be done as a part of general psychological 
assessment. Recently a comprehensive multi-item multi-scale self-report 
measure – Latvian Clinical Personality Inventory (LCPI; Perepjolkina, 
Koļesņikova, Mārtinsone, & Stepens, in press) had been developed in Latvia. The 
Depression Scale (DS, k = 24) is one of nine clinical scales1 of LCPI, along with
                                                          
1
 Other clinical scales of LCPI are: Symptoms of Posttraumatic Stress Disorder (PTSD), General Anxiety 
Symptoms (GA), Panic Attack Symptoms (PA), Symptoms of Social Anxiety (SA), Alcohol Related Problems 
(ALCO), Drug Related Problems (DRUG), Somatic Symptoms (SM) and Psychotic Symptoms (PSS). 
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33 personality-trait scales2, five functioning scales3 and five additional scales4. 
LCPI is available in a full (k = 322) and in a short version which is made up of 
first 220 items of LCPI, so also short version of DS scale (DSs) is available. 
DS/DSs scale for LCPI is developed for the assessment and monitoring of the 
severity of depression symptoms as a part of general psychological assessment in 
clinical, forensic and occupational settings.  
 
Development of DS and DSs scale for LCPI 
 
The DS scale is constructed based on Diagnostic and Statistical Manual of 
Mental Disorders 5th ed. (DSM–5; American Psychiatric Association [APA], 
2013) diagnostic criteria for Major Depressive Disorder (GDD), employing 
criterion related strategy for scale construction. In the initial test development 
stage at least two items were formulated for every criterion symptom listed DSM-
5 for major depressive disorder (APA, 2013, p. 160-161). In total, 65 items were 
formulated for DS scale on this stage. After discussions in a test development 
work-group, employing consensus approach 58 items (k1, Table 1) were retained 
for further content validity evaluation made by five external experts – three 
experienced practitioner psychiatrist and two clinical psychologists. As a result, 
50 survived items (k2, Table 1) for the DS scale were included in the second 
preliminary version of LCPI (Perepjolkina, Kolesnikova, Mārtinsone, Stepens, 
2016) for further empirical testing (see Table 1).  
  
                                                          
2
 LCPI personality trait model includes seven broad domains of personality trait variation – Narcissism (NR), 
Impulsivity (IM), Negative Affectivity (NA), Dependance (DE), Introversion (IN), Psychoticism (PSY) and 
Compulsivity (C) - comprising 33 specific personality trait facets (NR1: Dominance, NR2: Conceit, NR3: 
Attention seeking, NR4: Manipulativeness, NR5: Harshness; IM1: Aggression, IM2: Irresponsibility, IM3: 
Rashness, IM4: Risk taking; NA1: Intemperance, NA2: Emotional Stability, NA3: Emotional lability, NA4: 
Depressivity, NA5: Anxiousness, NA6: Impersistence (Distractibility), NA7: Distrustfulness; DE1: Evaluation 
apprehension, DE2: Submissiveness, DE3: Indecisiveness, DE4: Separation insecurity; PSY1: Cognitive 
dysregulation, PSY2: Dissociation proneness; PSY3: Eccentricity, PSY4: Suspiciousness, PSY5: Unusual beliefs, 
PSY6: Self-harm; IN1: Restricted affectivity. IN2: Social Withdrawal, IN3: Close relationship avoidance; C1: 
Pedantry, C2: Perseveration and C3: Perfectionism. 
3
 Five functioning scales of LCPI are: Sleep problems (F1), Energy level (F2), Psychomotor Retardation and 
Diminished Cognitive Function (F3), Problems associated with Attention Functions (F4), and Communication 
Problems (F5).  
4
 Additional scales of LCPI are: Suicide Ideation (SI), Self-esteem (SE), Stress Symptoms (STRS), Perceived 
Social Support (PSS) and Unstable and Intense Interpersonal Relationships (REL). 
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Table 1 Amount of Items for Every Criterion Symptom of Major Depressive Disorder 
Developed and Retained for Preliminary and Final Version of DS Scale for LCPI 
 
Symptoms/diagnostic criteria of Major 
depressive disorder (based in DSM-5) 
Amount of items aItem No. in 
LCPI 
k1 k2 k3 
Depressed mood  10 8 5 145, 113, 126, 
265, 289 
Marked diminished interest or pleasure in all, 
or almost all, activities 
7 7 4 74, 82, 115, 238 
Significant weight loss when not dieting or 
weight gain 
3 2 -- -- 
Insomnia or hypersomnia  8 7 2 119, 50 
Psychomotor agitation or retardation  4 4 2 122, 62 
Fatigue or loss of energy  6 5 4 134, 79, 1, 188 
Feelings of worthlessness or excessive or 
inappropriate guilt 
8 8 2 167, 290 
Diminished ability to think or concentrate 6 5 4 133, 281, 288, 307 
Recurrent thoughts of death or suicidal 
ideation  
6 4 1 68 
Note. k1 = amount of items retained after evaluation in the test development work-group; k2 = amount of 
items included in the second preliminary item pool of LCPI; k3 = amount of items included in the final 
version of DS scale for LCPI.  
aItems included in the short version of DS scale (DSs) are presented in bold face. 
 
Based on psychometric analysis, performed on the next test development 
stage, 24 best performing items (k3 in Table 1) were selected from the second 
preliminary item pool of LCPI for the inclusion to the final version of Depression 
scale (DS) for LCPI and 12 of these 24 items were selected for the short version 
of this scale (DSs) (see Table 1 and Table 3 for overview). Fifteen of 24 items are 
included not only in DS scale, but also in some other scales of LCPI, e.g. DS scale 
share two items with PTSD scale, one item with Stress symptoms scale and with 
Self-esteem scale, five items with F2 scale: Energy level; four items with F3 scale: 
Psychomotor retardation and diminished cognitive function, and two items with 
LCPI scale F1: Sleep problems (see Table 3).  
The main objective of this study was to evaluate the criterion validity and to 
estimate cut-off score of the Depression scale (DS) and short Depression scale 
(DSs) for LCPI. 
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Method 
 
Participants 
In total valid protocols5 of 888 adults (38.7 % male), who participated in the 
test development and primary validation study, were included in sample A (test 
development sample). Respondents ranged in age from 18 to 82 years with mean 
age of 36.23 (SD = 16.08) years. A part of sample A were inpatients, who received 
treatment in the psychiatric clinics (n = 153, sample P6, with mean age of 40.98 
(SD = 16.41) years, 43.7 % male), 36 of whom (sample P1, with mean age of 50.73 
(SD = 13.47) years, 24.3 % male) were inpatients with F32.0 - F33.11 diagnosis 
(based on ICD-10; WHO, 1992). For validation purposes a randomised 
community sample (n = 176, sample C, mean age 48.98 (SD = 16.42) years, 
43.8 % male) stratified by age and gender according to the proportions of these 
demographic characteristics in Latvian population were selected from sample A.  
Instruments 
All participants filled in demographic questionnaire indicating background 
information (age, sex, income level, marital status, level of education, 
occupational status and area of occupation), and completed a second preliminary 
item pool (k = 664) of Latvian Clinical Personality Inventory (Perepjolkina, 
Koļesnikova, Mārtinsone, Stepens, 2016) (items were answered on a 4-point 
response format: from 0 – ‘totally disagree’ to 3 – ‘totally agree’).  
The external criterion measure was a diagnosis of major depressive disorder 
(F32.0-F32.2 single episode (mild, moderate or severe without psychotic features) 
or F33.0-F33.2 recurrent (mild to severe without psychotic features)) (ICD-10; 
World Health Organisation, 1992) according to the medical records. 
Procedure 
Participation in the study was on a voluntary basis. All participants were 
required to meet the following criteria: (a) to be 18 years of age or older, (b) to be 
able to consent and complete the study protocol in Latvian. For psychiatric 
inpatient sample additional criteria were: (c) to endorse or exhibit current 
psychiatric symptoms, and (d) attending physician’s admission for a patient to 
                                                          
5
 The initial sample included 936 participants, but in total 48 protocols were eliminated as invalid (32 protocols 
(5.3 %) in community sample, and 16 protocols (9.5 %) in psychiatric inpatients sample). LCPI protocols were 
considered invalid in this study if more than 20 items (3 %) were left blank or if an answer on the last control-item 
(I have honestly answered to all questions) was ‘0’ or ‘1’. 
6 In this sample diagnoses included Mood disorder with major depressive-like episode due to known physiological 
condition (F06.32, n = 1), Personality and behavioral disorders due to known physiological condition (F07, n = 2), 
Alcohol related disorders (F10, n = 9), Schizophrenia (F20, n = 55), Schizotypal disorder (F21, n = 32), Brief 
psychotic disorder (F23, n = 5), Schizoaffective disorders (F25, n = 3), Bipolar disorder (F31, n = 3), Major 
depressive disorder, single episode (F32, n = 9), Major depressive disorder, recurrent (F33, n = 28), Generalized 
anxiety disorder (F41.1, n = 1), Reaction to severe stress, and adjustment disorders (F43, n = 4), and Somatoform 
disorders (F45, n = 2). 
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participate in the study. All psychiatric inpatients signed Informed Consent Form 
before participating in the study. 
Participants from psychiatric inpatient sample were contacted individually 
and after providing informed consent, participants were provided the packet of 
questionnaires to complete during their own time. From community sample data 
were collected mostly using an online platform employing snowball sampling 
method, but 27 % of participants (student subsample) were assessed frontally 
during their personality psychology study course and filed in paper-pencil 
versions of questionnaires for course credit. Data were collected from January 
2016 to November 2016 and all procedures were approved by the Riga Stradiņš 
University Ethical board. This study formed part of a LCPI development and 
validation research carried within the framework of Latvian National Research 
Programme Biomedicine for Public Health  (BIOMEDICINE) 2014 – 2017 (sub-
project Nr.5.8.2.). 
Data analysis 
Data were entered at the item level into a database and was analysed using 
IBM SPSS Statistics 20. Discrimination power of DS scale for LCPI on item-level 
was evaluated using (1) mean square contingency coefficient or phi (φ) 
coefficient – a correlation between an item (in dichotomized scoring format, were 
answers: 0’-‘totally disagree’ and ‘1’ – ‘partly disagree’ were coded as ‘0’ and 
answers: ‘2’ – ‘partly agree’ and ‘3’ – ‘totally agree’ – were coded as ‘1’) and 
criterion variable (‘0’ – a participant is from sample C, and ‘1’ – a participant is 
from sample P1); (2) Pearson product-moment correlation coefficient or 
Pearson’s r - a correlation between an item (using full range answer format) and 
criterion variable (‘0’ – sample C, ‘1’ – sample P1); (3) by analysis of item’s 
Discrimination index (D) (which was calculated using dichotomized scoring 
format), (4) by analysing a relative frequency of positive answers (in 
dichotomized scoring format) in C, P and P1 sample; (5) by calculating corrected 
item-total correlation (using full range scoring format) and (6) by using Student’s 
t-test for comparison of mean item scores (M) in C and P1 sample (using full range 
scoring format). Cronbach’s alpha coefficient was used to assess the internal 
consistency of the DS and DSs scale in different subsamples.  
For effect size estimation Hedges' g (Hedges, 1981), which provides a 
measure of effect size weighted according to the relative size of each sample was 
used7. The test performance (i.e. usefulness for identifying patients with major 
depression) of the DS and DSs scale was evaluated using receiver-operating 
characteristics (ROC) analyses. Areas under curve (AUC) indicated the accuracy 
                                                          
7
 Hedges’ g is an alternative measure of effect size, and in comparison to more traditionally used Cohen's d (which 
is the appropriate effect size measure if two groups have similar standard deviations and are of similar size). 
Hedges' g is more appropriate effect size measure if there are different sample sizes (Grissom & Kim, 2005; 
Stangroom, 2017) as it is in the case of our study.  
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of DS and DSs total raw scores to differentiate clinically diagnosed depression 
(sample P1) from potentially non-depression state (sample C), and were compared 
between subgroups using asymptotic tests of significance. Sensitivity, specificity, 
positive and negative predictive values (PPV and NPV) were calculated for 
different cut-off scores and the optimal cut-offs determined. For calculating 
positive predictive power (PPP) and negative predictive power (NPP) for various 
base rate indices (i.e. corrected for the prevalence or base rate of the condition in 
the population being tested) formulas provided by Streiner (2003, p. 213) were 
used.  
 
Results 
 
Item-level analysis 
Detailed item-level analysis revealed that all 24 item of final version of DS 
scale for LCPI show good to excellent discrimination power (see Table 2). For 
example, in dichotomized scoring format, frequency of positive answers in 
community sample (sample C) ranged from 4.00 % to 25.60 % (11.66 % in 
average) in comparison to sample P1 (patients with F32 - F33 diagnosis), where 
the frequency of positive answers ranged from 56.80 % to 94.60 % (74.13 % in 
average) and to sample P (patients who received treatment in the psychiatric 
clinics) where the frequency of positive answers ranged from 40.30 % to 66.90 % 
(50.98 % in average). In total sample discrimination index ranged from 0.51 to 
0.84 (0.65 in average), corrected item-total correlation indices ranged from 0.51 
to 0.87 (0.74 in average). Phi coefficient (φ) – a correlation between an item (in 
dichotomized scoring format) and criterion (‘0’ – sample C. ‘1’ – sample P1) 
ranged from 0.32 to 0.71 (0.58 in average), but using full range answer format, 
correlation between items and the same criterion ranged from 0.39 to 0.68 (0.58 
in average) (Table 2). 
Performed t-test analysis revealed that group differences (sample C vs. 
sample P1) on item-level (based on full-range response scale) were rather large 
(mean difference were 1.5 point in average) and highly significant (p ≤ .001) 
(Table 2).  
Scale-level analysis: Reliability and descriptive statistics 
The Cronbach’s alpha for internal consistency of the DS and DSs scale for 
LCPI in test development and validation sample (sample A) was 0.97 and 0.95 
accordingly, and ranged from 0.91 to 0.97 (for DS scale) and from 0.85 to 0.95 
(for DSs scale) for different subgroups (Table 2).  
Descriptive statistics for full and short version of Depression scale for LCPI 
for different subgroups are presented in Table 2. As it could be seen, in total and 
in psychiatric inpatient sample (A and P sample) almost full possible range of DS 
scale and full range of DSs scale total score is obtained. In randomised community 
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sample (sample C) no one scored higher than 53 for DS scale and higher than 26 
for DSs scale, but in sample P1 (patients with GDD) the lowest total score was 18 
for DS scale and 4 for DSs scale. Therefore, DS scale’s scores for the sample C 
ranged from 0 to 53, with a mean score of 10.78 (SD = 11.17), in contrast, DS 
scores for sample P ranged from 0 to 71 with a mean score of 34.26 (SD = 18.66) 
and DS scores for sample P1 ranged from 18 to 70 with a mean score of 46.49 
(SD = 13.84) (Table 2).  
 
Table 2 Reliability Coefficients (Cronbach’s α) and Descriptive Statistics of DS 
and DSs Scale for LCPI 
 
Statistics α M (SD) Range 
Sample DS DSs DS DSs DS DSs 
A sample  .97 .95 20.50 (19.32 ) 9.75 (10.03) 0-71 0-36 
C sample  .93 .87 10.78 (11.17) 4.76 (5.48) 0-53 0-26 
C male (Cm) .93 .85 7.92 (9.53) 3.27 (4.31) 0-47 0-18 
C female (Cf) .93 .87 13.00 (11.87) 5.91 (6.01) 0-53 0-26 
P sample .95 .92 34.26 (18.66) 17.05 (9.85) 0-71 0-36 
P1 sample  .91 .86 46.49 (13.84) 21.97 (7.53)  18-70 4-35 
Note. DS – Depression Scales for LCPI. DSs – Short Depression Scale for LCPI.  
α – Cronbach’s alfa. Sample A (N = 888) = test development total sample; sample C (n = 176) = 
community sample; sample Cm (n = 77) = male subsample from sample C; sample Cf (n = 99) = female 
subsample from sample C; sample P (n = 153) = clinical sample (patients who received treatment in the 
psychiatric clinics), sample P1 (n = 37) = patients with F32 - F33 diagnosis (based on ICD-10). Possible 
range for DS scale total score is from 0 to 72 and for DSs scale – from 0 to 36. 
 
An independent samples t-test revealed that these differences were very large 
and statistically significant ((1) sample C vs. sample P: t (241.12) = -13.59, 
p ≤ 0.001, g = 1.55 (very large effect size) and (2) sample C vs. sample P1: 
t (46.36) = -14.72. p ≤ 0.001, g = 3.06 – huge effect size8). Very large and 
statistically significant differences were obtained also for DSs scale scores: 
sample C: M = 4.76 (SD = 5.48) vs. sample P: M = 17.05 (SD = 9.85), t (230.18) = -
13.70, p ≤ 0.001, g = 1.57 (very large effect size), and sample C: M = 4.76 
(SD = 5.48) vs. sample P1: M = 21.97 (SD = 7.53), t (44.32) = -17.13, p ≤ 0.001, 
g = 2.92 (huge effect size). Additional analysis revealed, that females from sample 
C scored significantly higher than males both for full and short version of 
Depression Scale for LCPI (Mfemale = 13.00 (11.88), Mmale = 7.92 (9.53), 
t (174) = 3.06, p < .001, g = 0.46 (small effect size) for DS scale, and 
Mfemale =  5.91 (6.01), Mmale = 3.27 (4.31), t (174) = 3.25, p < .001, g = 0.49 (small 
effect size) for DSs scale), but these differences were relatively small in 
magnitude. Such gender related differences is in line with empirically approved 
higher prevalence rate of GDD in females in general (e.g. Ayuso-Mateos et al., 
                                                          
8
 According to Sawilowsky (2009). 
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2001; Marcus et al., 2005) and in Latvian population as well (Pulmanis, Japeniņa, 
Taube, 2016; Rancans, Vrublevska, Kivite, et al., 2016).  
Scale-level analysis: Criterion validity 
In Table 4 diagnostic efficiency statistics on scale level are reported using 
multiple cut-off scores. Overall, the area under the curve was 0.97 for DS scale 
and 0.96 for DSs scale. Performed analysis revealed that DS score greater than 26 
points and DSs score greater than 12 points reasonably balanced sensitivity and 
specificity rates. For DS scale sensitivity was 0.95 and specificity was 0.91 at cut-
off of raw score = 26 points and for DSs scale sensitivity was 0.92 and specificity 
was 0.89 at the cut-off of raw score = 12 points.  
Unlike sensitivity and specificity, positive predictive power (PPP or PPV) 
and negative predictive power (NPP or NPV) are not fixed characteristics of a 
scale and are dependent on the prevalence (i.e., base rate) of the condition being 
assessed (Meehl & Rosen, 1955; Streiner, 2003). Thus, in Table 4 PPP and NPP 
are presented for multiple base rate estimates. Base rate estimates of 5%, 10%, 
15%, 20% and 25% are considered. Given that, the prevalence of general 
depression is likely to vary across settings and patient populations, reporting PPP 
and NPP allows examiners to adjust risk tolerance accordingly. Table 4 displays 
diagnostic efficiency statistics for multiple base rate estimates. 
 
Discussion 
 
Performed analysis revealed that both full and short version of Depression 
Scale (DS and DSs) for LCPI show good to excellent diagnostic efficiency both 
on item and on scale level. Determined optimal cut-off score for DS scale 
correctly classified 95 % of patients with GDD (F32 - F33 diagnosis) and for DSs 
scale proportion of correctly classified patients was 92 %. That means, that 
diagnostic efficiency for DSs is somewhat lower in comparison to DS, but still it 
is reasonably high even in comparison to other popular self-report measures of 
GDD. For example, the 2002 literature review (Williams, Pignone, Ramirez, & 
Perez Stellato, 2002) found that median sensitivity across 16 instruments, 
including the BDI, CES-D, MDRS, PHQ and MDI9, for major depression was 
85%, ranging from 50-97%, while median specificity was 74%, ranging from 51-
98%.   
  
                                                          
9
 Beck Depression Inventory (BDI), Centre for Epidemiologic Studies Depression Scale (CES-D), Hamilton 
Depression Rating Scale (HDRS), Patient Health Questionnaire (PHQ), Major Depression Inventory (MDI).  
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Table 3 Item-Level Analysis of Discriminating Power for the LCPI Depression Scale  
(DS and DSs) 
 
Sample C P1 P C vs. P1 
C vs. 
P1 A C P1 t Main idea of a content of 
item & item No. f1% f2% f3% φ r D 
CIT
C M (SD) M (SD) 
145. Depressed mood (DSs)  7.4 78.4 55.2 .68 .68 .72 .87 0.38 (0.67) 2.08 (0.86) -13.31*** 
 74. Inability to feel joy 
(DSs, PTSD, STRS) 11.4 83.8 55.8 .64 .68 .72 .85 0.40 (0.73) 2.22 (0.85) -13.31*** 
126. Feelings of inner 
emptiness (DSs)  6.3 67.6 48.7 .62 .63 .70 .83 0.27 (0.61) 1.78 (1.08) -8.31*** 
 82. Indifference for 
everything (DSs)  6.3 64.9 40.3 .60 .66 .58 .82 0.24 (0.58) 1.81 (1.02) -8.46*** 
115. Loss of interest for 
living (DSs)  5.7 64.9 47.4 .61 .64 .61 .83 0.20 (0.57) 1.68 (1.03) -8.24*** 
289. Feelings that ‘life is 
empty’  6.8 64.9 40.9 .59 .62 .59 .82 0.26 (0.67) 1.81 (1.08) -11.40*** 
238. Loss of interest (in 
general) (PTSD)  5.7 67.6 43.5 .63 .60 .58 .80 0.27 (0.62) 1.70 (1.13) -7.52*** 
113. Negative view on 
future    8.0 64.9 42.2 .56 .56 .54 .75 0.38 (0.76) 1.84 (1.04) -8.07*** 
 68.Do not want to live (DSs)  6.8 56.8 45.5 .52 .48 .57 .55 0.27 (0.67) 1.29 (1.21) -9.25*** 
167. Feelings of worth-
lessness (SE) (DSs)  9.1 75.7 49.4 .62 .64 .67 .81 0.36 (0.64) 1.95 (1.00) -12.27*** 
290. Excessive guilt 13.6 73.0 41.8 .53 .49 .51 .51 0.52 (0.76) 1.70 (0.97) -12.33*** 
265. Feelings of loneliness  12.5 67.6 55.2 .50 .55 .72 .76 0.44 (0.77) 1.89 (1.10) -9.24*** 
134.Loss of energy (DSs, F3) 16.5 94.6 66.9 .65 .65 .83 .81 0.63 (0.78) 2.35 (0.75) -12.18*** 
  79. Fatigue (‘no reason 
why’) (F3) 16.5 94.6 65.6 .65 .65 .82 .79 0.65 (0.85) 2.49 (0.69) -9.02*** 
    1. Fatigue (feel tired 
sooner than usually) (F3) 21.6 91.9 62.3 .56 .58 .84 .78 0.72 (0.93) 2.41 (0.72) -8.47*** 
188. Fatigue & loss of 
energy (F3) 13.1 78.4 56.5 .58 .58 .78 .78 0.54 (0.76) 2.08 (1.04) -7.66*** 
133. Diminished ability to 
concentrate (DSs) 10.2 78.4 54.5 .62 .60 .65 .72 0.41 (0.70) 1.86 (0.92) -10.82*** 
  62. ‘Slow mode of 
thinking’ (DSs, F2) 13.6 78.4 55.8 .57 .60 .68 .75 0.52 (0.77) 2.08 (0.92) -10.78*** 
122. Psychomotor 
retardation (DSs, F2) 11.9 75.7 48.1 .57 .59 .59 .73 0.43 (0.78) 2.00 (1.03) -10.53*** 
 281.Absent-mindedness (F2) 14.2 73.0 51.9 .52 .51 .56 .62 0.61 (0.78) 1.89 (0.94) -8.70*** 
288. Diminished cognitive 
function (F2)  4.0 73.0 48.7 .71 .63 .53 .70 0.34 (0.59) 1.78 (0.98) -8.67*** 
307. Problems with 
memory (F2) 11.4 86.5 57.1 .66 .62 .73 .78 0.55 (0.74) 2.11 (0.84) -11.40*** 
119. Sleep problems (F1) 25.6 64.9 46.8 .32 .39 .58 .56 0.76 (0.92) 1.81 (1.18) -5.15*** 
  50. Insomnia (DSs, F1) 21.6 59.5 43.5 .32 .40 .58 .56 0.64 (0.88) 1.70 (1.15) -5.29*** 
Note.  f1. f2. f3% = relative frequency of positive answers (in dichotomized scoring format); φ = phi coefficient – 
a correlation between an item (in dichotomized scoring format) and criterion (‘0’ – sample C. ‘1’ – sample P1); 
r = a correlation between an item and criterion (full range answer format); D = discrimination index 
(dichotomized scoring format); CITC = corrected item-total correlation; M = reaction index. ***p < .001. DSs = 
Short Depression scale for LCPI; F1 = LCPI scale Sleep problems; F2 = LCPI scale Energy level; F3 = LCPI 
scale Psychomotor retardation and diminished cognitive function; SE = LCPI scale Self-esteem; PTSD = LCPI 
scale Posttraumatic stress disorder; STRS =   LCPI scale Stress symptoms. 
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Table 4 Diagnostic Efficiency Statistics of the Depression scale (DS) and Short 
Depression scale (DSs) for LCPI for Different Cut-offs Using the Samples P1 and C 
 
Cut-off 
score 
Sensiti-
vity 
Speci-
ficity PPV NPV LR+ LR- 
Base Rate Estimates 
0.05 0.10 0.15 0.20 0.25 
PPP NPP PPP NPP PPP NPP PPP NPP PPP NPP 
Raw score of Depression scale (DS) for LCPI 
DP ≥ 24 0.95 0.89 0.64 0.99 8.64 17.80 0.31 1.00 0.49 0.99 0.60 0.99 0.68 0.99 0.74 0.98 
DP ≥ 26 0.95 0.91 0.69 0.99 10.56 18.20 0.36 1.00 0.54 0.99 0.65 0.99 0.73 0.99 0.78 0.98 
DP ≥ 28 0.92 0.92 0.71 0.98 11.50 11.50 0.38 1.00 0.56 0.99 0.67 0.98 0.74 0.98 0.79 0.97 
Raw score of Short Depression scale (DSs) for LCPI 
DPs ≥ 10 0.97 0.84 0.56 0.99 6.06 28.00 0.24 1.00 0.40 1.00 0.52 0.99 0.60 0.99 0.67 0.99 
DPs ≥ 11 0.95 0.86 0.59 0.99 6.79 17.20 0.26 1.00 0.43 0.99 0.54 0.99 0.63 0.99 0.69 0.98 
DPs ≥ 12 0.92 0.89 0.63 0.98 8.36 11.13 0.31 1.00 0.48 0.99 0.60 0.98 0.68 0.98 0.74 0.97 
DPs ≥ 13 0.89 0.91 0.67 0.98 9.89 8.27 0.34 0.99 0.52 0.99 0.64 0.98 0.71 0.97 0.77 0.96 
DPs ≥ 14 0.86 0.91 0.67 0.97 9.56 6.50 0.33 0.99 0.51 0.98 0.63 0.97 0.70 0.96 0.76 0.95 
 
Notes. Area under ROC curve (AUC) for DS scale = 0.969 (0.948 – 0.990) and for DSs scale = 0.963 (0.945 – 
0.991) (figures in parenthesis indicate 95% confidence limits, asymptotic tests, under non-parametric 
assumptions). PPV = positive predictive value (Streiner, 2003, Formula No. 5, p. 212); NPV = negative predictive 
value (Streiner, 2003, formula No. 6, p. 212); LR+ = Likelihood ratio for positive tests (Sensitivity/(1-Specificity)) 
(Streiner. 2003, formula No. 3, p. 211); LR- = Likelihood ratio for negative test (Specificity/(1-Sensitivity)) 
(Streiner, 2003, formula No. 4, p. 211); PPP = positive predictive power (value) corrected for the prevalence or 
base rate of the condition in the population being tested (Streiner, 2003, formula No. 15, p. 213); NPP = negative 
predictive power (value) corrected for the prevalence or base rate of the condition in the population being tested 
(Streiner. 2003, formula No. 17, p. 213). Sample P1 = patients with F32 - F33 diagnosis (based on ICD-10) 
(n = 37). Sample C = non-clinical randomised community sample (n = 176). 
 
While for determined optimal cut-off sensitivity in this study of DS was 95% 
and specificity 91%, while for DSs sensitivity was 92% and specificity 89%. In 
comparison sensitivity of PHQ-9 Latvian language version was only 74.7% and 
specificity 84.0%, correctly classifying 83.2% patients (Rancans et al, 2016). 
Sensitivity, specificity, and the LRs are generally seen as fixed properties of 
the test. That is, as long as the test is used with similar groups of people, these 
attributes should not change. However, if the test is used with people who have 
different amounts of the trait in question, then sensitivity and specificity will have 
to be recalculated; for example, a test validated on inpatients with mild or severe 
depression will likely have different properties when used with outpatients with 
dysthymia. So in future, it would be necessary to test diagnostic efficiency of DS 
and DSs in outpatient sample with dysthymia, as well as to test relative test 
performance (both on scale and on item-level) among different gender, age, and 
physical chronic illness groups, and separately for inpatients with mild, moderate 
and severe depression. Future studies should test whether the DS/DSs is effective 
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instrument for screening of depression in different contexts (e.g. educational, 
occupational, forensic) and is it effective tool for monitoring changes in severity 
of symptoms of depression during the course of treatment.  
The main limitation of DS and even of DSs scale as an instrument for 
screening of depression is that these are no ‘independent’ scale, but are made up 
of items spread among other items of LCPI, which is rather long (k = 322 – full 
version and k = 220 – short version), so it could be difficult for patients with 
depression and for seniors to retain concentration and motivation and to fill-in this 
inventory completely and in consistent manner. So, for targeted screening of 
depressive disorder special screening instruments (e.g. PHQ-9) would be more 
appropriate.  
The main limitations of this study are (1) small sample size both for inpatient 
with GDD group and for community sample group; (2) semi-representative 
sample of community population randomly selected from the non-clinical 
subsample of test development sample, and (3) no additional criterion was used 
for the control of severity of depression symptoms in community sample.  Given 
this, it remain possible that the subjects who were included as ‘controls’ might 
have been GDD-positive in reality. It could be possible, especially considering 
their proportion in sample C, which is 9.1% both of DS and for DSs (based on DS 
score ≥ 26, and DSs score ≥ 12), which corresponds reasonably well to the 
prevalence rate of depressive disorder estimated in general population of Latvia 
and in primary care settings (Rancans et al., 2014; Rancans, Vrublevska, Kivite, 
et al., 2016; Vrublevska et al, 2017).  
Next limitation of this study is that no additional criterion, accept diagnosis 
based on medical records, was used in inpatient sample. On the other hand, 
partially verification bias was avoided in the present study because diagnosis of 
major depression on all the subjects from psychiatric inpatient sample was made 
irrespective of the results of the DS screening test. Nonetheless, the positive 
predictive value was high (69% for DS and 63% for DSs). 
In future validation studies of DS and DSs for LCPI it would be useful to 
analyse different characteristics of true versus false positives (based on cut-off 
scores of DS/DSs scale), for example, it was shown in other studies that false 
positives show higher rates of anxiety symptomatology, previous depressive 
episodes, somatic complains, alcohol and nicotine consumption (e.g. Haringsma, 
Engels, Beekman, & Spinhoven, 2004).  
 
Conclusions 
 
DS and DSs of LCPI is proved to have good criterion validity in detecting 
depression while using LCPI for the overall psychological assessment, and to be 
a reliable and valid instrument for assessment of depression symptoms in patients 
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with depression and in general population. Subjects scoring ≥ 26 points on DS or  
≥ 12 on DSs constitute a target group for further diagnostic assessment in order 
to determine appropriate treatment. 
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